Make a Donation

Policy Statement Number 9 August 2002 There are many misperceptions and misunderstanding about the federal regulations and particularly when it comes to issues regarding raising the dose over 100 mgs. Prior to the HIV epidemic in order to raise a patient’s dose it was required for the physician to contact the Food and Drug Administration…

Paul Edward Bowman (1963-2021) NAMA Recovery    In Memoriam    December 3, 2021  |  0 NAMA Recovery is saddened to report the passing of a long-standing member of our Board of Directors. Paul Edward Bowman, Jr, 58, passed away on November 22, 2021. Paul was born in Boston, MA and lived most of his life…

Herman Joseph, PhD 1931 – 2019 May 28, 2019 May 6, 2019 Dr. Joseph was one of the important influences on addiction and criminal justice during the latter 20th and early 21st century.  For more than 50 years he has worked as a social research scientist in the interrelated fields of addiction, treatment, criminal justice,…

FDA Warns About Orlaam T01-15 Print Media: 301-827-6242 April 20, 2001 Broadcast Media: 301-827-3434   Consumer Inquiries: 888-INFO-FDA The U.S. Food and Drug Administration (FDA) issued a new warning about health risks associated with levomethadyl acetate HC, a.k.a. Orlaam, a drug used to treat opiate addiction. FDA Announces Labeling Changes Following Cardiac Adverse Events With…

Starting Patrol Heading for the bicycle Tom Jensen starts on his daily patrol to search out used syringes left on the streets last night. First Check The yellow jacket marked “Sprøjte Patruljen” lets the community know that they are safe and BF is on the job picking up used syringes and other paraphernalia. A Syringe…

This is a super-duper double issue of The Ombudsman and I think that you’ll agree with me that it is the best one yet. With each issue I worry because I believe that the issue is so good that it just could not be “topped” and I don’t want the next issue to be disappointing….